Emergency response and recovery workers, law enforcement and construction workers who reported to the World Trade Center site after 9/11 had a twofold higher risk for myeloma precursor disease compared with the general population.
The study findings, published in Blood Cancer Journal, suggest providing these responders with access to screening for the precursor disease, monoclonal gammopathy of undetermined significance (MGUS), could allow for therapeutic interventions that extend survival.
C. Ola Landgren, MD, PhD, professor of medicine, chief of the myeloma program in the division of
